Connection

Daniel Steinberg to Prosthesis Design

Back to Details
This is a "connection" page, showing publications Daniel Steinberg has written about Prosthesis Design.
Daniel Steinberg
Connection Strength
0.677
Prosthesis Design
  1. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud? in patients with stroke or transient ischemic attack. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1262-7.
    View in: PubMed
    Score: 0.109
  2. Advances in transcatheter valve therapies. J Cardiovasc Transl Res. 2014 Jun; 7(4):375-86.
    View in: PubMed
    Score: 0.102
  3. Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
    View in: PubMed
    Score: 0.090
  4. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
    View in: PubMed
    Score: 0.077
  5. Snare extraction of a fractured coronary stent in a saphenous vein graft. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):241-3.
    View in: PubMed
    Score: 0.064
  6. Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation. J Cardiovasc Transl Res. 2019 04; 12(2):142-149.
    View in: PubMed
    Score: 0.034
  7. Functioning Cooley-Cutter aortic valve prosthesis 40 years after implantation. J Thorac Cardiovasc Surg. 2014 Mar; 147(3):e21-2.
    View in: PubMed
    Score: 0.025
  8. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv. 2013 Feb; 81(2):348-55.
    View in: PubMed
    Score: 0.022
  9. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv. 2009 Nov 15; 74(6):889-95.
    View in: PubMed
    Score: 0.019
  10. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
    View in: PubMed
    Score: 0.018
  11. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
    View in: PubMed
    Score: 0.018
  12. Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
    View in: PubMed
    Score: 0.018
  13. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):799-803.
    View in: PubMed
    Score: 0.018
  14. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
    View in: PubMed
    Score: 0.016
  15. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Feb 01; 101(3):293-9.
    View in: PubMed
    Score: 0.016
  16. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):167-72.
    View in: PubMed
    Score: 0.016
  17. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.